Rossi, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 592
EU - Europa 401
AS - Asia 76
OC - Oceania 3
AF - Africa 2
SA - Sud America 2
Totale 1.076
Nazione #
US - Stati Uniti d'America 590
SE - Svezia 131
IT - Italia 88
DE - Germania 40
CN - Cina 32
IE - Irlanda 32
PL - Polonia 30
FI - Finlandia 22
FR - Francia 20
IN - India 18
GB - Regno Unito 17
BE - Belgio 8
HK - Hong Kong 6
UA - Ucraina 6
IR - Iran 5
SG - Singapore 5
VN - Vietnam 3
AT - Austria 2
AU - Australia 2
CA - Canada 2
KR - Corea 2
LK - Sri Lanka 2
NL - Olanda 2
TR - Turchia 2
BR - Brasile 1
CH - Svizzera 1
CI - Costa d'Avorio 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 1.076
Città #
Chandler 152
Ashburn 53
New York 42
Dublin 32
Ann Arbor 31
Warsaw 30
Rome 29
Fairfield 21
Houston 20
Wilmington 19
Helsinki 17
Princeton 14
San Mateo 13
Woodbridge 13
Marseille 12
Beijing 11
Jacksonville 11
Milan 11
Nanjing 10
Boston 9
Seattle 8
Brussels 7
Pune 7
Bremen 6
Dearborn 6
Detroit 6
Hong Kong 6
London 6
Busto Arsizio 5
San Diego 5
Cambridge 4
Lappeenranta 4
Cattolica 3
Dong Ket 3
Hebei 3
Lancaster 3
Los Angeles 3
Washington 3
Ankara 2
Campobasso 2
Catania 2
Colombo 2
Meppel 2
Monza 2
Nanchang 2
Norwalk 2
Novara 2
Paris 2
Redwood City 2
Seoul 2
Abidjan 1
Ardea 1
Auburn Hills 1
Auckland 1
Boardman 1
Brisbane 1
Bristol 1
Buffalo 1
Chiavenna 1
Chicago 1
Chiswick 1
Clearwater 1
Dallas 1
Edinburgh 1
Frankfurt am Main 1
Gurgaon 1
Haikou 1
Hangzhou 1
Hefei 1
Hounslow 1
Jinan 1
Kensington 1
Kish 1
Kunming 1
Lawrence 1
Leawood 1
Liedekerke 1
Lima 1
Livorno 1
Melbourne 1
Miami 1
Monmouth Junction 1
Munich 1
Nova Iguaçu 1
Nuremberg 1
Nürnberg 1
Pioltello 1
Pomezia 1
Portland 1
Sacrofano 1
San Jose 1
Shanghai 1
Singapore 1
Stockholm 1
Tappahannock 1
Timisoara 1
Vienna 1
Vittuone 1
Winnipeg 1
Zanjan 1
Totale 712
Nome #
Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study 130
Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1) 107
Reader response: High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2 78
Response to "Autosomal recessive axonal neuropathy caused by HINT1 mutation: New association of a psychiatric disorder to the neurological phenotype" 75
Application of a Clinical Workflow May Lead to Increased Diagnostic Precision in Hereditary Spastic Paraplegias and Cerebellar Ataxias: A Single Center Experience 70
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 68
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 66
Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2 55
Pathological findings in chronic inflammatory demyelinating polyradiculoneuropathy: A single-center experience 54
A next generation sequencing-based analysis of a large cohort of ataxic patients refines the clinical spectrum associated with spinocerebellar ataxia 21 49
Clarification on Uveal Melanoma Associated With Myotonic Dystrophy 43
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1) 42
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 42
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience 41
Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network 39
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 38
Ngs in hereditary ataxia: When rare becomes frequent 30
Clinical Reasoning: A Young Man With Subacute Onset of Spastic Paraparesis 28
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1) 14
Neurological Erdheim-Chester Disease Manifesting with Subacute or Progressive Cerebellar Ataxia: Novel Case Series and Review of the Literature 13
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease 13
Power of NGS-based tests in HSP diagnosis: analysis of massively parallel sequencing in clinical practice 10
Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature 1
Totale 1.106
Categoria #
all - tutte 5.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/202075 13 2 2 0 6 2 5 2 10 9 20 4
2020/2021120 6 5 7 8 14 4 12 4 17 14 22 7
2021/2022180 14 11 3 33 6 9 6 24 8 15 22 29
2022/2023445 49 47 23 65 31 51 18 36 71 12 29 13
2023/2024234 11 50 11 22 6 62 31 3 15 11 12 0
Totale 1.106